Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (94 ms)
| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1160.65/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.65 |
| Version | 20241016 |
| Status | active |
| Date | 2024-10-16T01:07:54-04:00 |
| Name | DirectReninInhibitorForHypertension |
| Title | Direct Renin Inhibitor for Hypertension |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Direct Renin Inhibitor pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Direct Renin Inhibitor pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Direct Renin Inhibitor pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1160.65",
"meta" : {
"versionId" : "8",
"lastUpdated" : "2024-11-26T11:15:10.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "HSAG Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-10-16"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-10-16"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.65",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1160.65"
}
],
"version" : "20241016",
"name" : "DirectReninInhibitorForHypertension",
"title" : "Direct Renin Inhibitor for Hypertension",
"status" : "active",
"date" : "2024-10-16T01:07:54-04:00",
"publisher" : "American Medical Association Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Direct Renin Inhibitor pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Direct Renin Inhibitor pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Direct Renin Inhibitor pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1011710",
"display" : "aliskiren 150 MG / hydrochlorothiazide 12.5 MG Oral Tablet"
},
{
"code" : "1011713",
"display" : "aliskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet"
},
{
"code" : "1011736",
"display" : "aliskiren 150 MG Oral Tablet"
},
{
"code" : "1011739",
"display" : "aliskiren 300 MG Oral Tablet"
},
{
"code" : "1011750",
"display" : "aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet"
},
{
"code" : "1011753",
"display" : "aliskiren 300 MG / hydrochlorothiazide 25 MG Oral Tablet"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:a126a154-7652-4f60-8db1-c9e62ab884f1",
"timestamp" : "2024-12-10T07:17:38-05:00",
"total" : 6,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1011710",
"display" : "aliskiren 150 MG / hydrochlorothiazide 12.5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1011713",
"display" : "aliskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1011736",
"display" : "aliskiren 150 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1011739",
"display" : "aliskiren 300 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1011750",
"display" : "aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1011753",
"display" : "aliskiren 300 MG / hydrochlorothiazide 25 MG Oral Tablet"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR